HU0000282A3 - Improvements in or relating to contrast agents - Google Patents

Improvements in or relating to contrast agents

Info

Publication number
HU0000282A3
HU0000282A3 HU0000282A HU0000282A HU0000282A3 HU 0000282 A3 HU0000282 A3 HU 0000282A3 HU 0000282 A HU0000282 A HU 0000282A HU 0000282 A HU0000282 A HU 0000282A HU 0000282 A3 HU0000282 A3 HU 0000282A3
Authority
HU
Hungary
Prior art keywords
relating
improvements
contrast agents
contrast
agents
Prior art date
Application number
HU0000282A
Other versions
HU224218B1 (en
HU0000282A2 (en
Original Assignee
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GBGB9621884.7A priority Critical patent/GB9621884D0/en
Priority to GBGB9708239.0A priority patent/GB9708239D0/en
Application filed by Ge Healthcare As filed Critical Ge Healthcare As
Priority to PCT/GB1997/002898 priority patent/WO1998017324A2/en
Publication of HU0000282A2 publication Critical patent/HU0000282A2/en
Publication of HU0000282A3 publication Critical patent/HU0000282A3/en
Publication of HU224218B1 publication Critical patent/HU224218B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/22Echographic preparations; Ultrasound imaging preparation Optoacoustic imaging preparations
    • A61K49/222Echographic preparations; Ultrasound imaging preparation Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/904Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927Diagnostic contrast agent
    • Y10S977/928X-ray agent
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/904Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927Diagnostic contrast agent
    • Y10S977/929Ultrasound contrast agent
HU0000282A 1996-10-21 1997-10-21 Improvements in or relating to contrast agents HU224218B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9621884.7A GB9621884D0 (en) 1996-10-21 1996-10-21 Improvements in or relating to contrast agents
GBGB9708239.0A GB9708239D0 (en) 1997-04-23 1997-04-23 Improvements in or relating to contrast agents
PCT/GB1997/002898 WO1998017324A2 (en) 1996-10-21 1997-10-21 Improvements in or relating to contrast agents

Publications (3)

Publication Number Publication Date
HU0000282A2 HU0000282A2 (en) 2000-05-28
HU0000282A3 true HU0000282A3 (en) 2001-09-28
HU224218B1 HU224218B1 (en) 2005-06-28

Family

ID=26310262

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000282A HU224218B1 (en) 1996-10-21 1997-10-21 Improvements in or relating to contrast agents

Country Status (26)

Country Link
US (3) US6375931B2 (en)
EP (2) EP1007100B1 (en)
JP (1) JP2001502349A (en)
KR (1) KR20000052652A (en)
CN (1) CN1106859C (en)
AP (1) AP885A (en)
AT (2) AT381353T (en)
AU (1) AU745047B2 (en)
BG (1) BG103402A (en)
BR (1) BR9712370A (en)
CA (1) CA2269319C (en)
CZ (1) CZ9901409A3 (en)
DE (4) DE69738406T2 (en)
EE (1) EE03749B1 (en)
ES (1) ES2197336T3 (en)
HU (1) HU224218B1 (en)
ID (1) ID21681A (en)
IL (1) IL129423A (en)
MX (1) MXPA99003664A (en)
NO (1) NO991869A (en)
NZ (1) NZ335265A (en)
PL (1) PL332820A1 (en)
RU (1) RU2204415C2 (en)
SK (1) SK283210B6 (en)
TR (1) TR199901544T2 (en)
WO (1) WO1998017324A2 (en)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774278B1 (en) 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
AU725693B2 (en) * 1996-03-12 2000-10-19 Board Of Regents Of The University Of Nebraska, The Targeted site specific drug delivery compositions and method of use
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
WO1998010798A1 (en) * 1996-09-11 1998-03-19 Imarx Pharmaceutical Corp. Improved methods for diagnostic imaging using a contrast agent and a vasodilator
DE69738406T2 (en) * 1996-10-21 2008-12-04 Ge Healthcare As Improvements in or on contrast agents
GB9708246D0 (en) 1997-04-24 1997-06-18 Nycomed Imaging As Improvements in or relating to ultrasound imaging
GB9717588D0 (en) * 1997-08-19 1997-10-22 Nycomed Imaging As Improvements in or relating to contrast agents
EP1024837A1 (en) * 1997-10-21 2000-08-09 Nycomed Imaging As Ultrasound imaging with contrast agent targeted to microvasculature and a vasodilator drug
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
DE19805012A1 (en) * 1998-02-07 1999-08-12 Thomas Gieselmann Contrast agents for use as diagnostic agents in imaging methods, as well as its preparation
GB9808599D0 (en) * 1998-04-22 1998-06-24 Nycomed Imaging As Improvements in or realting to contrast agents
GB9808582D0 (en) * 1998-04-22 1998-06-24 Nycomed Imaging As Improvements in or relating to contrast agents
US20040170564A1 (en) * 1998-04-22 2004-09-02 Roald Skurtveit Ultrasound contrast agent dispersions comprising gas and destabilising agent
GB9808581D0 (en) * 1998-04-22 1998-06-24 Nycomed Imaging As Improvements in or relating to contrast agents
GB9813568D0 (en) * 1998-06-23 1998-08-19 Nycomed Imaging As Improvements in or relating to cardiac imaging
US6984373B2 (en) 2000-12-23 2006-01-10 Dyax Corp. Fibrin binding moieties useful as imaging agents
NO20010234D0 (en) * 2001-01-12 2001-01-12 Nycomed Imaging As Perfusion imaging image
US7179449B2 (en) * 2001-01-30 2007-02-20 Barnes-Jewish Hospital Enhanced ultrasound detection with temperature-dependent contrast agents
DE10115740A1 (en) * 2001-03-26 2002-10-02 Ulrich Speck Preparation for the prophylaxis of restenosis
US20040166152A1 (en) * 2002-02-14 2004-08-26 Andreas Hirsch Use of buckysome or carbon nanotube for drug delivery
US20080193490A1 (en) * 2002-02-14 2008-08-14 Andreas Hirsch Use of Carbon Nanotube for Drug Delivery
EP2014310B8 (en) 2002-03-01 2012-12-26 Dyax Corp. KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
CA2513044A1 (en) 2002-03-01 2004-08-05 Dyax Corp. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
US20090060992A1 (en) * 2002-05-08 2009-03-05 University Of Central Florida Research Foundation, Inc., Preparation of magneto-vesicles with DOPE/DDAB layers
WO2003097125A2 (en) * 2002-05-17 2003-11-27 Case Western Reserve University Double contrast technique for mri-guided vascular interventions
AU2003270689A1 (en) * 2002-09-19 2004-04-08 New York University Control of nitric oxide bioactivity by perfluorocarbons
DE10244847A1 (en) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck A medical device for drug delivery
DK1593091T3 (en) * 2003-01-25 2013-10-28 Seno Medical Instr Inc Acousto-optic imaging with high contrast by the use of non-spherical nanoparticles
US20040146461A1 (en) * 2003-01-29 2004-07-29 Vincenzo Giuliano Oral contrast media composition for computerized axial tomographic examinations and method
US7378081B2 (en) 2003-01-29 2008-05-27 Vincon Research Enterprises, Llc Composition and method for direct visualization of the human appendix
DE602004008590T2 (en) * 2003-01-31 2008-05-21 Otsuka Pharmaceutical Factory, Inc., Naruto Adjuvant cancer therapy method for use in cancer therapy by means of dielectric loss and
ES2352087T3 (en) * 2003-02-04 2011-02-15 Bracco Suisse Sa Ultrasound contrast agents and process for preparation thereof.
US20070128117A1 (en) * 2003-02-04 2007-06-07 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
SI2949658T1 (en) 2003-03-03 2018-10-30 Dyax Corp. Peptides that specifically bind HGF receptor (cMet) and uses thereof
US20040258760A1 (en) * 2003-03-20 2004-12-23 Wheatley Margaret A. Isolated nanocapsule populations and surfactant-stabilized microcapsules and nanocapsules for diagnostic imaging and drug delivery and methods for their production
US20080299047A1 (en) * 2003-07-31 2008-12-04 National Cheng Kung University Method for preparation of water-soluble and dispersed iron oxide nanoparticles and application thereof
SE526838C2 (en) * 2003-11-27 2005-11-08 Xcounter Ab Observation Method and apparatus for the detection of ionizing radiation
AU2004308756B2 (en) * 2003-12-22 2010-06-24 Bracco Suisse S.A. Gas-filled microvesicle assembly for contrast imaging
CA2562606A1 (en) * 2004-04-13 2005-10-27 Cambridge Biostability Limited Liquids containing suspended glass particles
US8012457B2 (en) * 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation
US9248204B2 (en) * 2004-08-18 2016-02-02 Bracco Suisse S.A. Gas-filled microvesicles composition for contrast imaging
US8034222B2 (en) * 2004-10-26 2011-10-11 The Regents Of The University Of California Conducting polymer nanowire sensors
US8153435B1 (en) 2005-03-30 2012-04-10 Tracer Detection Technology Corp. Methods and articles for identifying objects using encapsulated perfluorocarbon tracers
US20070167861A1 (en) * 2005-11-29 2007-07-19 Lopez George A Cardiac output measurement devices and methods
EP1966388B1 (en) 2005-12-09 2013-08-07 Bracco Suisse SA Targeting vector-phospholipid conjugates
WO2007100886A2 (en) * 2006-02-28 2007-09-07 E. I. Du Pont De Nemours And Company Azeotropic compositions comprising fluorinated compounds for cleaning applications
CN100400105C (en) * 2006-05-11 2008-07-09 上海交通大学 Aqueous matrix CT negative contrast medium for digestive tract and its preparation method
JP4279328B2 (en) * 2007-05-07 2009-06-17 株式会社日立製作所 Ultrasound imaging system
KR100957560B1 (en) * 2007-10-18 2010-05-11 한국생명공학연구원 Perfluorocarbon Nano Emulsion Containing Quantum Dot Nanoparticles and Method for Preparing Thereof
GB0811856D0 (en) * 2008-06-27 2008-07-30 Ucl Business Plc Magnetic microbubbles, methods of preparing them and their uses
CN102165455B (en) * 2008-09-30 2015-08-26 皇家飞利浦电子股份有限公司 Perfusion Imaging
US9072490B2 (en) * 2010-12-20 2015-07-07 Toshiba Medical Systems Corporation Image processing apparatus and image processing method
ITRM20110022A1 (en) * 2011-01-21 2012-07-22 Gaio Paradossi Method for the preparation of microbubbles comprising a contrast agent
RU2454174C2 (en) * 2011-03-16 2012-06-27 Федеральное государственное учреждение "Московский научно-исследовательский онкологический институт им. П.А. Герцена" Министерства здравоохранения и социального развития Российской Федерации (ФГУ "МНИОИ им. П.А. Герцена" Минздравсоцразвития России) Method of diagnosing cervical tumours
RU2453270C1 (en) * 2011-03-31 2012-06-20 Федеральное государственное учреждение "Московский научно-исследовательский онкологический институт им. П.А. Герцена Министерства здравоохранения и социального развития Российской Федерации" (ФГУ "МНИОИ им. П.А. Герцена" Минздравсоцразвития России) Method of examining terminal part of large intestine
RU2485976C2 (en) * 2011-05-17 2013-06-27 Государственное образовательное учреждение высшего профессионального образования "Сибирский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации (ГОУ ВПО СибГМУ Минздравсоцразвития России) Contrast medium for ultrasonic imaging
KR20150003221A (en) * 2012-04-30 2015-01-08 지이 헬스케어 에이에스 Method for filling a container with a foamable composition
DK2864033T3 (en) * 2012-06-26 2016-05-17 Ge Healthcare As Preparation of composition comprising gas microbubbles
CN103100093B (en) * 2013-01-23 2015-05-06 中山大学附属第三医院 Load small interfering RNA nanoscale lipid microbubble ultrasonic contrast agent and preparation method
US20160243234A1 (en) * 2013-09-27 2016-08-25 Phoenix Solutions As Ultrasound mediated delivery of drugs
JP2018503629A (en) 2014-12-31 2018-02-08 ランセウス メディカル イメージング, インコーポレイテッド Lipid encapsulation gas microspheres compositions and related methods
US9789210B1 (en) 2016-07-06 2017-10-17 Lantheus Medical Imaging, Inc. Methods for making ultrasound contrast agents

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5070877A (en) * 1988-08-11 1991-12-10 Medco Research, Inc. Novel method of myocardial imaging
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5773024A (en) * 1989-12-22 1998-06-30 Imarx Pharmaceutical Corp. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5117830A (en) * 1990-11-08 1992-06-02 Whitby Research, Inc. Method of determining viability of tissue
PL176116B1 (en) * 1993-01-25 1999-04-30 Sonus Pharmaceuticals,Inc. Colloidal suspensions able to undergo phase transitions for use as usg contrast media
US5362478A (en) * 1993-03-26 1994-11-08 Vivorx Pharmaceuticals, Inc. Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
US5716597A (en) * 1993-06-04 1998-02-10 Molecular Biosystems, Inc. Emulsions as contrast agents and method of use
US5798091A (en) * 1993-07-30 1998-08-25 Alliance Pharmaceutical Corp. Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
AT281183T (en) * 1993-07-30 2004-11-15 Alliance Pharma Stabilized mikrogasblaeschen-compositions for Echografie
DE4406474A1 (en) * 1994-02-23 1995-08-24 Schering Ag Gas containing microparticles, compositions comprising them, their use in ultrasound diagnosis, as well as methods for producing the particles, and means
GB9423419D0 (en) * 1994-11-19 1995-01-11 Andaris Ltd Preparation of hollow microcapsules
US5560364A (en) * 1995-05-12 1996-10-01 The Board Of Regents Of The University Of Nebraska Suspended ultra-sound induced microbubble cavitation imaging
US5804162A (en) * 1995-06-07 1998-09-08 Alliance Pharmaceutical Corp. Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
DE69738406T2 (en) * 1996-10-21 2008-12-04 Ge Healthcare As Improvements in or on contrast agents
US6054118A (en) * 1997-01-22 2000-04-25 Nycomed Imaging As Contrast agents comprising two types of gas-containing microparticles

Also Published As

Publication number Publication date
HU224218B1 (en) 2005-06-28
NO991869A (en) 1999-06-02
DE69738406T2 (en) 2008-12-04
US20050118104A1 (en) 2005-06-02
DE69721331T2 (en) 2004-05-06
AU745047B2 (en) 2002-03-07
US20040141921A1 (en) 2004-07-22
RU2204415C2 (en) 2003-05-20
NZ335265A (en) 2000-07-28
SK283210B6 (en) 2003-03-04
JP2001502349A (en) 2001-02-20
AT238073T (en) 2003-05-15
IL129423D0 (en) 2000-02-17
AU4714797A (en) 1998-05-15
DE69721331D1 (en) 2003-05-28
US20010002993A1 (en) 2001-06-07
HU0000282A2 (en) 2000-05-28
CZ9901409A3 (en) 1999-09-15
EE03749B1 (en) 2002-06-17
KR20000052652A (en) 2000-08-25
AP885A (en) 2000-11-03
US6375931B2 (en) 2002-04-23
WO1998017324A3 (en) 1998-06-25
BG103402A (en) 2000-01-31
EE9900158A (en) 1999-12-15
IL129423A (en) 2003-01-12
EP1264604A3 (en) 2004-03-10
DE69738406D1 (en) 2008-01-31
ID21681A (en) 1999-07-08
CN1106859C (en) 2003-04-30
AT381353T (en) 2008-01-15
EP1264604A2 (en) 2002-12-11
WO1998017324A2 (en) 1998-04-30
TR199901544T2 (en) 1999-09-21
MXPA99003664A (en) 2002-06-11
EP1264604B1 (en) 2007-12-19
CA2269319C (en) 2008-03-18
CA2269319A1 (en) 1998-04-30
EP1007100B1 (en) 2003-04-23
BR9712370A (en) 1999-08-31
CN1238699A (en) 1999-12-15
NO991869D0 (en) 1999-04-19
US6783752B2 (en) 2004-08-31
AP9901511A0 (en) 1999-06-30
EP1007100A2 (en) 2000-06-14
PL332820A1 (en) 1999-10-11
SK52099A3 (en) 2000-01-18
ES2197336T3 (en) 2004-01-01

Similar Documents

Publication Publication Date Title
DE69834346D1 (en) Proteinexpression in baculovirus-vektor expressionsystemen
GB2309942B (en) Improvements in or relating to an air-bag
GB2337987B (en) Improvements in or relating to containers
GB2330126B (en) Improvements in or relating to dispensers
IL129444D0 (en) Improvements in or relating to diagnostic/therapeutic agents
GB9727295D0 (en) Improvements in or relating to steplessly-variable-ratio transmission apparatus
SG52338A1 (en) Improvements in or relating to contrast agents
HU9402565D0 (en) Improvements in or relating to contrast agents
GB9200391D0 (en) Improvements in or relating to contrast agents
GB9200387D0 (en) Improvements in or relating to contrast agents
HK1003293A1 (en) Improvements in or relating to contrast agents
MX9807863A (en) Improvements in or relating to encapsulation
GB2321004B (en) Improvements in or relating to enclosures
GR3036412T3 (en) Improvements in or relating to clamping arrangements
GB9705132D0 (en) Improvements in or relating to tillage
IL129445D0 (en) Improvements in or relating to diagnostic/therapeutic agents
GB9726664D0 (en) Improvements in or relating to ultrasonography
IL126834D0 (en) Improvements in or relating to endoscopes
GB9318288D0 (en) Improvements in or relating to contrast agents
GB2320435B (en) Improvements in Magnotherapy
GB9612615D0 (en) Improvements in or relating to an air-bag
GB9614994D0 (en) Improvements in or relating to coupling bodies
GB9418146D0 (en) Improvements in or relating to pipe-laying
GB2311053B (en) Improvements in or relating to securing packages
GB9618635D0 (en) Improvements in or relating to sensors

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20050510

HC9A Change of name, address

Owner name: GE HEALTHCARE AS, NO

Free format text: FORMER OWNER(S): AMERSHAM HEALTH AS, NO; NYCOMED IMAGING AS, NO

MM4A Lapse of definitive patent protection due to non-payment of fees